Category OAFI News

22 Feb

Study finds why Osteoarthritis is more common in women than in men

On the occasion of the celebration of Articulando el Deporte, on 8, 9 and 10 March in Madrid, we bring you this article published some time ago, which explains the prevalence of osteoarthritis in women compared to men. Women suffer more from osteoarthritis than men. A group of experts from Augusta University in Georgia (USA) […]

3 Feb

OAFI, Teaming Up With The Best, to Change Oosteoarthritis

OAFI FOUNDATION HOSTED THE LAUNCHING OF THE ORGANIZATION EUROPEAN COOPERATION IN SCIENCE AND TECHNOLOGY On January 23rd and 24th, in Barcelona, the OAFI Foundation hosted the launching of the European Cooperation in Science and Technology, (COST), a funding organization for research and innovation networks at European level in the field of osteoarthritis. At these meetings, […]

15 Dec

OAFI Radio wins first prize in the audiovisual media category of the 13th Grünenthal Foundation Journalism Awards

OAFI Radio’s programme “Fibromyalgia, chronic fatigue syndrome and adequate exercise” has been awarded first prize in the Grünenthal Foundation’s Journalism Awards, dedicated to chronic pain, in the audiovisual media category. On 12 December, the OAFI Foundation won first prize in the 13th Grünenthal Foundation Journalism Awards for audiovisual media, which aim to recognise the work […]

9 Dec

OAFI, representing osteoarthritis patients, is received at the Vatican

On Wednesday, 16 November, OAFI was granted an audience with His Holiness Pope Francis, where we were able to bring the reality of osteoarthritis to this institution. Dr. Josep Vergés, President of OAFI, and Maria Teresa Vergés, Director of the OAFI Patients’ Area, together with Dr. Ingrid Möller and Dr. Jose María Villalón, recognised experts […]

30 Jun

Chuso García Bragado, OAFI Foundation and Kern Pharma award the first García Bragado-OAFI-Kern Pharma scholarships to promising future athletes

– The scholarships will help 6 young athletes from our country to develop their sports career in an optimal and healthy way. – The award ceremony took place this Tuesday at Kern Pharma’s headquarters in Terrassa (Barcelona). The Osteoarthritis Foundation International (OAFI), the pharmaceutical laboratory Kern Pharma and the Olympic athlete Jesús Ángel García Bragado […]

16 Jun

OAFI and the University of Alcalá sign a collaboration agreement to work together in osteoarthritis research

The agreement, signed this Tuesday by Dr. Josep Vergés, Founder and President of OAFI, and Prof. F. Javier de la Mata, Vice-Rector for Research and Transfer of the University of Alcalá, will focus on pharmacological research into osteoarthritis and the locomotor system. The Osteoarthritis Foundation International (OAFI) and the University of Alcalá (UAH), have signed […]

26 May

AECOSAR participates and receives the SORCOM award for the ARTRO 360 project

AECOSAR participated this past Sunday, May 22, in the II Solidarity Race for Patients with Rheumatic Diseases, organized by the Society of Rheumatology of the Community of Madrid (SORCOM). They were also awarded for the support of the ARTRO 360 project, an initiative of OAFI Foundation in which AECOSAR collaborates, consisting of a proposal for […]

28 Feb

Banco Farmacéutico, OAFI and AECOSAR join forces to work towards the eradication of pharmaceutical poverty in patients with osteoarthritis and/or osteoporosis

The Osteoarthritis Foundation International (OAFI), the Spanish Osteoporosis Association (AECOSAR) and the Banco Farmacéutico, together with the Observatorio de la Pobreza Farmacéutica, signed an agreement last January establishing a joint working framework to curb pharmaceutical poverty in patients with osteoarthritis and/or osteoporosis. OAFI is the world’s first and only non-profit foundation exclusively for people with […]

3 Dec

OAFI Foundation and SEIOMM sign a collaboration framework to bring doctors and patients together in the research of osteoarthritis and osteoporosis.

Last November, SEIOMM (Spanish Society for Bone and Mineral Metabolism Research) and the Osteoarthritis Foundation International (OAFI) signed a collaboration agreement between both parties, in which they undertook to work together to tackle osteoarthritis and osteoporosis. Osteoarthritis, a chronic disease erroneously associated with old age, already affects more than 7 million people in Spain, with […]

8 Jul

Patients and Experts Agree: Vitamin D Should Be Included in Primary Care Analysis

On June 29, the Asociación Nacional de Informadores de la Salud (ANIS), together with Agencia Raíz, organized the debate “Vitamin D: controversies and evidence 2021”, in which the impact of vitamin D on the population and on patients with osteoporosis was discussed. With invited experts in the sector such as Dr. Francisco López Medrano, physician […]

OAFI is the International Osteoarthritis Foundation, the first and only foundation aimed exclusively at people with osteoarthritis worldwide.

CONTACT

The Foundation

Actions